← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 1993Last known activity
Jan 31, 2025
Timeline
1990s
- Jan 1, 1993
European Union— Founded
Drugs by trial phase (67 distinct, 43 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (15 own, 0 via acquisition)
- 68ga-neobomb1
- prednisone
- methylphenidate
- dronabinol
- Nesolicaftor
- snn0031
- tetrahydrocannabinol
- vamorolone
- allogeneic adipose derived mesenchymal stem cell
- umbilical cord mesenchymal stem cells
- donor-derived ebv-specific cytotoxic t-cells transduced with the retroviral vector sfgalpha-cd19-cd3zeta
- irradiated donor lymphocyte
- Posenacaftor
- pti-808
- slamf7 car-t
Phase 1 (17 own, 0 via acquisition)
Indications
Studied for
- Abdominal Pain
- Asthma
- Attention Deficit Disorder with Hyperactivity
- Brain Neoplasms
- Bronchopulmonary Dysplasia
- Cholangitis
- Cholangitis, Sclerosing
- Chronic Pain
- Dementia
- Diabetes Mellitus, Type 1
- Gastrointestinal Stromal Tumors
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Hepatitis
- Hepatitis, Autoimmune
- HIV Infections
- Hyperkinesis
- Hyperplasia
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid, Acute
- Lymphoma
- Malaria
- Malaria, Falciparum
- Meningitis
- Multiple Myeloma
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Neoplasms, Plasma Cell
- Pancreatitis
- Pancreatitis, Chronic
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Problem Behavior
- Sleep Deprivation
- Tuberculosis
- Tuberculosis, Meningeal
- Ventricular Dysfunction
- Ventricular Dysfunction, Left
- Whooping Cough
Recent trials (43)
- NCT06681402CollaboratorPhase 1Jan 31, 2025
- NCT06468527CollaboratorPhase 2Jun 3, 2024
- NCT06158698CollaboratorPhase 3Nov 14, 2023
- NCT06039358CollaboratorN/AOct 6, 2023
- NCT04839146CollaboratorPhase 1Mar 11, 2021
- NCT04499339CollaboratorPhase 1/Phase 2Jul 22, 2020
- NCT04145258CollaboratorPhase 3Apr 1, 2020
- NCT03439670CollaboratorPhase 2Jun 19, 2018
- NCT02997878CollaboratorPhase 1/Phase 2Jun 1, 2017
- NCT03341403CollaboratorPhase 2/Phase 3Jan 17, 2017
- NCT02673164CollaboratorPhase 2Jan 1, 2017
- NCT02931929CollaboratorPhase 1/Phase 2Oct 1, 2016
- NCT02778360CollaboratorPhase 1/Phase 2Aug 1, 2016
- NCT02408562CollaboratorPhase 1/Phase 2Jan 31, 2015
- NCT02526004CollaboratorN/AJan 1, 2015
Details
- Founded
- Brussels, BE Jan 1, 1993
- Last known activity
- Jan 31, 2025